Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status-Reference-Cited by-同舟云学术

Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status

Published:2016-03 Issue:3 Volume:22 Page:289.e1-289.e7
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Servais S.,Dumontier N.,Biard L.,Schnepf N.,Resche-Rigon M.,Peffault de Latour R.,Scieux C.,Robin M.,Meunier M.,Xhaard A.,Sicre de Fontbrune F.,Le Goff J.,Socié G.,Simon F.,Mazeron M.-C.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference25 articles.

1. Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis;Ljungman;Blood,2003

2. Influence of donor cytomegalovirus (CMV) status on severity of viral reactivation after allogeneic stem cell transplantation in CMV-seropositive recipients;Pietersma;Clin Infect Dis,2011

3. Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies;Özdemir;Bone Marrow Transplant,2007

4. Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients;Zhou;Blood,2009

5. CMV infections after hematopoietic stem cell transplantation;Ljungman;Bone Marrow Transplant,2008

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective comparison of cytomegalovirus quantification in whole blood and plasma samples among hematopoietic stem cell transplant and kidney transplant recipients;Journal of Clinical Virology;2024-10

2. Letermovir as secondary prophylaxis of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: A single center experience;European Journal of Haematology;2024-06-21

3. Post-transplant malignancy: Focusing on virus-associated etiologies, pathogenesis, evidence-based management algorithms, present status of adoptive immunotherapy and future directions;World Journal of Meta-Analysis;2023-12-18

4. Cytomegalovirus Infection Post-Allogeneic Stem Cell Transplantation: Experience from a Country with High Seropositivity;Transplantation and Cellular Therapy;2023-08

5. Epidemiology, treatment patterns, and disease burden of cytomegalovirus in hematopoietic cell transplant recipients in selected countries outside of Europe and North America: A systematic review;Transplant Infectious Disease;2023-06-08